Galante, S.; Castillo, R.; Price, T.; Tran, M.; Stramel-Stafford, S.
Assessing Clinical Outcomes of Metronidazole for Intra-Abdominal Infections When Dosed Every 12 h Versus Every 8 h in a Multi-Center Health System. Antibiotics 2025, 14, 688.
https://doi.org/10.3390/antibiotics14070688
AMA Style
Galante S, Castillo R, Price T, Tran M, Stramel-Stafford S.
Assessing Clinical Outcomes of Metronidazole for Intra-Abdominal Infections When Dosed Every 12 h Versus Every 8 h in a Multi-Center Health System. Antibiotics. 2025; 14(7):688.
https://doi.org/10.3390/antibiotics14070688
Chicago/Turabian Style
Galante, Sarah, Ramya Castillo, Todd Price, MaiCuc Tran, and Stefanie Stramel-Stafford.
2025. "Assessing Clinical Outcomes of Metronidazole for Intra-Abdominal Infections When Dosed Every 12 h Versus Every 8 h in a Multi-Center Health System" Antibiotics 14, no. 7: 688.
https://doi.org/10.3390/antibiotics14070688
APA Style
Galante, S., Castillo, R., Price, T., Tran, M., & Stramel-Stafford, S.
(2025). Assessing Clinical Outcomes of Metronidazole for Intra-Abdominal Infections When Dosed Every 12 h Versus Every 8 h in a Multi-Center Health System. Antibiotics, 14(7), 688.
https://doi.org/10.3390/antibiotics14070688